Researchers have identified hundreds of new and known microRNAs in the domestic dog genome, a finding that could contribute to disease research.
The FDA, journals, and even payors are encouraging labs to deposit variant data in public databases, but collaboration is needed to resolve interpretation discrepancies.
Sanger Institute researchers analyzed the genomes and mutational signatures of 560 breast cancer tumors, identifying new ways to classify the disease.
Questions remain about how the €6.7 billion ($7.6 billion) pledged for the implementation of the European Open Science Cloud over the next four years will be spent.
In addition to the hepatitis C panel, the company offers a number of next-generation sequencing-based tests including one for colorectal cancer.
The startup will use the fund to begin commercialization of its PCR-based VerifyDx prostate cancer test.
The company is developing a proteomic test for chronic obstructive pulmonary disease that it plans to launch in early 2018 as a CLIA-based diagnostic.
The revenue spike was due to an increase in the number of Atlas molecular testing platforms placed with commercial customers.
In Science this week: CRISPR-based approach to identify gene variants, and more.
Stat News profiles the Wellcome Trust's Jeremy Farrar.
France's research minister tells Nature News that he hopes to simplify the research bureaucracy and improve funding.
A recent study examines how a paper, despite being retracted, can influence its field, Retraction Watch reports.
This webinar highlights important features and demonstrates the practical aspects of using the NCBI BLAST service.
This on-demand webinar demonstrates how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.
This online seminar demonstrates how RNA-seq analysis in a model organism can provide insights into human disease.